Catalogo dei prodotti della ricerca

ZINGAROPOLI, MARIA ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.567
NA - Nord America 1.414
AS - Asia 625
SA - Sud America 59
AF - Africa 24
OC - Oceania 1
Totale 3.690
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.386
IT - Italia 789
SG - Singapore 366
RO - Romania 202
SE - Svezia 197
IN - India 99
DE - Germania 97
CN - Cina 79
FI - Finlandia 50
BR - Brasile 49
RU - Federazione Russa 48
ID - Indonesia 45
BG - Bulgaria 32
GB - Regno Unito 30
IE - Irlanda 25
CA - Canada 22
NL - Olanda 21
AT - Austria 20
FR - Francia 18
TG - Togo 11
LT - Lituania 9
BE - Belgio 8
MY - Malesia 8
AR - Argentina 6
UA - Ucraina 6
HK - Hong Kong 5
TR - Turchia 5
MK - Macedonia 4
CZ - Repubblica Ceca 3
EG - Egitto 3
MX - Messico 3
PK - Pakistan 3
SA - Arabia Saudita 3
TN - Tunisia 3
AL - Albania 2
JP - Giappone 2
NG - Nigeria 2
PH - Filippine 2
RS - Serbia 2
SC - Seychelles 2
AU - Australia 1
AZ - Azerbaigian 1
BJ - Benin 1
BO - Bolivia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ES - Italia 1
HN - Honduras 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KR - Corea 1
LV - Lettonia 1
MA - Marocco 1
PA - Panama 1
PE - Perù 1
PL - Polonia 1
PS - Palestinian Territory 1
QA - Qatar 1
TJ - Tagikistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 3.690
Salva come PNG Salva come JPEG
Città #
Rome 341
Singapore 217
Horia 186
Chandler 184
Fairfield 138
Ashburn 122
Milan 69
Woodbridge 63
Cambridge 51
Santa Clara 50
Houston 48
Seattle 45
Jakarta 44
Princeton 42
Wilmington 42
Dearborn 41
San Paolo di Civitate 32
Sofia 32
New York 31
Helsinki 30
Cosenza 28
Lawrence 26
Dublin 22
Nuremberg 22
Fremont 21
Millbury 20
Beijing 19
Plano 18
Boston 17
Ann Arbor 16
Moscow 15
Los Angeles 14
Munich 14
Naples 14
San Diego 14
Padova 13
Toronto 13
Boardman 11
Lomé 11
London 11
Stockholm 11
Yubileyny 10
Andover 9
Council Bluffs 9
Lappeenranta 9
San Mateo 9
Brussels 8
Falkenstein 8
Shanghai 8
Ottawa 7
Florence 6
Hyderabad 6
São Paulo 6
Vignola 6
Ascoli Piceno 5
Federal 5
Frankfurt am Main 5
Hong Kong 5
Norwalk 5
Phoenix 5
Artena 4
Deiva Marina 4
Delhi 4
Guangzhou 4
Jundiaí 4
Lamezia Terme 4
Latina 4
Licenza 4
Mannheim 4
Paris 4
Porto Recanati 4
Portsmouth 4
Pune 4
Redwood City 4
Sabaudia 4
Amsterdam 3
Bari 3
Brno 3
Bühl 3
Chapel Hill 3
Des Moines 3
Frabosa Sottana 3
Genoa 3
Hebei 3
Hefei 3
Lidköping 3
Pocapaglia 3
Portland 3
Venezia 3
Vienna 3
Abuja 2
Araras 2
Arielli 2
Bologna 2
Bonita Springs 2
Casamassima 2
Crevalcore 2
Falls Church 2
Ferrara 2
Fiumicino 2
Totale 2.414
Salva come PNG Salva come JPEG
Nome #
FECAL MICROBIOTA TRANSPLANTATION VIA ENEMA FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION MODULATES THE INFLAMMATORY HOST RESPONSE AND RESTORE INTESTINAL DYSBIOSIS 185
Fecal microbial transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent clostridium difficile infection patients 161
Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis 135
Dynamic changes of mmp-9 plasma levels correlate with jvc reactivation and immune activation in natalizumab-treated multiple sclerosis patients 98
Reactivation of hepatitis B virus with immune-escape mutations after ocrelizumab treatment for multiple sclerosis 98
Human polyomavirus JC replication and non coding control region analysis in multiple sclerosis patients under natalizumab treatment 97
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters 96
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study 94
Higher levels of osteoprotegerin and immune activation/immunosenescence markers are correlated with concomitant bone and endovascular damage in HIV-suppressed patients 91
Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical hiv-associated atherosclerosis 91
Archetype and rearranged non-coding control regions (NCCR) in urothelial bladder carcinoma of immunocompetent individuals 88
Increased sCD163 and sCD14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID-19 pneumonia 86
Natalizumab affects T-cell phenotype in multiple sclerosis: implications for JCV reactivation 85
Major reduction of NKT cells in patients with severe COVID-19 pneumonia 84
JCPyV NCCR analysis in PML patients with different risk factors: Exploring common rearrangements as essential changes for neuropathogenesis 83
Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia. A retrospective cohort study 79
Modificazioni immunofenotipiche dei linfociti T in pazienti affetti da sclerosi multipla in trattamento con natalizumab: implicazioni per la riattivazione del JC virus 74
Chest computed tomography score, cycle threshold values and secondary infection in predicting COVID-19 mortality 74
Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment 72
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus 70
Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease 69
The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia 67
Comparison of FTD SARS-CoV-2 Assay and RealStar RT-PCR kit 1.0 for the detection of SARS-CoV-2 67
Evaluation of immunogenicity to three doses of the SARS-CoV-2 BNT162b2 mRNA vaccine in lung transplant patients 65
CD49d expression on T lymphocytes and CD8 effector percentage as predictors of JC virus reactivation in multiple sclerosis patients on natalizumab treatment. 61
Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients 61
HIV-associated progressive multifocal leukoencephalopathy. Current perspectives 60
Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis? 60
COVID-19 vaccination in cancer patients: Immune responses one year after the third dose 57
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine 57
Evaluation of the anti-proliferative activity of violacein, a natural pigment of bacterial origin, in urinary bladder cancer cell lines 56
Breakthrough infections after Covid-19 vaccinations do not elicit platelet hyper-activation and associate with high platelet-lymphocyte and low platelet-neutrophil aggregates 55
PaO2/FiO2 ratio forecasts COVID-19 patients’ outcome regardless of age: a cross-sectional, monocentric study 55
Human Polyomavirus JC monitoring and CD49d expression in dynamic cohorts of multiple sclerosis patients treated with natalizumab: an observational study. 54
Small fibre neuropathy frequently underlies the painful long-COVID syndrome 52
Neuro-axonal damage and alteration of blood-brain barrier integrity in COVID-19 patients 52
Biomarkers of neurological damag. From acute stage to post-acute sequelae of covid-19 52
Blood biomarkers from the emergency department disclose severe omicron covid-19-associated outcomes 50
Human Polyomavirus JC monitoring in dynamic cohorts of multiple sclerosis patients treated with natalizumab: an observational study 50
Quality of t-cell response to SARS-CoV-2 mrrna vaccine in art-treated plwh 49
Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection 47
COVID-19 affects serum brain-derived neurotrophic factor and neurofilament light chain in aged men. Implications for morbidity and mortality 46
Systemic, mucosal immune activation and psycho-sexual health in art-suppressed women living with HIV. Evaluating biomarkers and environmental stimuli 46
B- and T-cell responses after SARS-CoV-2 vaccination in patients with multiple sclerosis receiving disease modifying therapies. Immunological patterns and clinical implications 45
Polyomaviruses NCCR sequence analysis in urothelial bladder carcinoma of immunocompetent individuals. 44
Neurofilament assessment in patients with cervical dystonia 43
Evaluation of BAFF, APRIL and CD40L in ocrelizumab-treated pwMS and infectious risk 41
Longitudinal virological and immunological profile in a case of human monkeypox infection 40
Immunogenicity and efficacy of vaccination in people living with human immunodeficiency virus 39
Determinanti di salute: nuovi percorsi per la ricerca scientifica 37
null 35
The impact of Cytomegalovirus infection on natural killer and CD8+ t cell phenotype in multiple sclerosis 34
Tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) and pulmonary involvement in COVID-19 pneumonia 34
Hepatitis B-related hepatic flare during immune reconstitution syndrome after antiretroviral treatment initiation in an HBV surface antigen-positive patient with HIV. Viroimmunological and histological characterization 34
Blood count and renal functionality assessments in the emergency section disclose morbidity and ortality in omicron COVID-19 patients: a retrospective study 33
null 30
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection 28
null 27
The long-term Immunogenicity of mRNABNT162b third vaccine dose in solid organ transplant recipients 25
Baseline myeloid and lymphoid activation markers can predict time to viral load reduction under 50 copies/mL and CD4 recovery, respectively, after highly active antiretroviral therapy initiation 25
Neurofilament expression as a biomarker of post-COVID-19 sudden sensorineural hearing loss 24
Cardiovascular risk in HIV-positive subjects: analyses of T-cell phenotype and CD49d expression 24
Insights into Long COVID: Unraveling Risk Factors, Clinical Features, Radiological Findings, Functional Sequelae and Correlations: A Retrospective Cohort Study 23
Impact of ifn-free and ifn-based treatment on blood myeloid dendritic cell, monocyte, slan-dc, and activated t lymphocyte dynamics during hcv infection 23
SARS-CoV-2 vaccination influence in the development of long-COVID clinical phenotypes 7
Totale 3.924
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.529
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020106 0 0 0 0 0 0 0 0 35 43 16 12
2020/2021366 12 21 11 184 3 27 3 6 27 42 11 19
2021/2022564 9 8 55 48 54 28 42 44 50 29 133 64
2022/2023738 92 135 72 64 89 73 24 57 40 12 49 31
2023/2024658 19 51 19 73 76 110 13 59 14 95 45 84
2024/20251.091 50 88 92 158 119 157 114 111 202 0 0 0
Totale 3.924